CA2211003A1 - Recepteur du facteur de necrose des tumeurs humain - Google Patents

Recepteur du facteur de necrose des tumeurs humain

Info

Publication number
CA2211003A1
CA2211003A1 CA002211003A CA2211003A CA2211003A1 CA 2211003 A1 CA2211003 A1 CA 2211003A1 CA 002211003 A CA002211003 A CA 002211003A CA 2211003 A CA2211003 A CA 2211003A CA 2211003 A1 CA2211003 A1 CA 2211003A1
Authority
CA
Canada
Prior art keywords
polypeptide
receptor
polynucleotide
dna
tnf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002211003A
Other languages
English (en)
Inventor
John M. Greene
Robert D. Fleischmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to PCT/US1995/003216 priority Critical patent/WO1996028546A1/fr
Priority to ZA952587A priority patent/ZA952587B/xx
Priority to US08/469,637 priority patent/US7094564B1/en
Application filed by Individual filed Critical Individual
Priority to CA002211003A priority patent/CA2211003A1/fr
Publication of CA2211003A1 publication Critical patent/CA2211003A1/fr
Priority to JP2002066838A priority patent/JP2002320479A/ja
Priority to US10/164,592 priority patent/US20020150989A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002211003A 1995-03-15 1997-09-19 Recepteur du facteur de necrose des tumeurs humain Abandoned CA2211003A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PCT/US1995/003216 WO1996028546A1 (fr) 1995-03-15 1995-03-15 Recepteur humain du facteur de necrose tumorale
ZA952587A ZA952587B (en) 1995-03-15 1995-03-29 Human tumor necrosis factor receptor
US08/469,637 US7094564B1 (en) 1995-03-15 1995-06-06 Human tumor necrosis factor receptor
CA002211003A CA2211003A1 (fr) 1995-03-15 1997-09-19 Recepteur du facteur de necrose des tumeurs humain
JP2002066838A JP2002320479A (ja) 1995-03-15 2002-03-12 ヒト腫瘍壊死因子受容体
US10/164,592 US20020150989A1 (en) 1995-03-15 2002-06-10 Human tumor necrosis factor receptor

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US1995/003216 WO1996028546A1 (fr) 1995-03-15 1995-03-15 Recepteur humain du facteur de necrose tumorale
ZA952587A ZA952587B (en) 1995-03-15 1995-03-29 Human tumor necrosis factor receptor
CA002211003A CA2211003A1 (fr) 1995-03-15 1997-09-19 Recepteur du facteur de necrose des tumeurs humain
JP2002066838A JP2002320479A (ja) 1995-03-15 2002-03-12 ヒト腫瘍壊死因子受容体

Publications (1)

Publication Number Publication Date
CA2211003A1 true CA2211003A1 (fr) 1999-03-19

Family

ID=31721537

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002211003A Abandoned CA2211003A1 (fr) 1995-03-15 1997-09-19 Recepteur du facteur de necrose des tumeurs humain

Country Status (4)

Country Link
JP (1) JP2002320479A (fr)
CA (1) CA2211003A1 (fr)
WO (1) WO1996028546A1 (fr)
ZA (1) ZA952587B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919434B1 (en) 1995-02-20 2005-07-19 Sankyo Co., Ltd. Monoclonal antibodies that bind OCIF
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US8110659B1 (en) 1995-03-15 2012-02-07 Human Genome Sciences, Inc. Human tumor necrosis factor receptor-like genes
US7078493B1 (en) 1995-03-15 2006-07-18 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor-like genes
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin
US7632922B1 (en) 1995-12-22 2009-12-15 Amgen, Inc. Osteoprotegerin
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
EP0961832A4 (fr) * 1996-09-18 2003-02-26 Human Genome Sciences Inc Genes de type recepteurs du facteur de necrose tumorale humain
EP0960196A4 (fr) * 1996-10-04 2002-10-29 Immunex Corp Nouveau recepteur provoquant la mort cellulaire
JP4138013B2 (ja) 1996-12-23 2008-08-20 イミュネックス・コーポレーション Ｔｎｆスーパーファミリーのメンバーであるｎｆ−ｋａｐｐａ ｂの受容体アクティベーターに対するリガンド
US5885800A (en) * 1997-02-04 1999-03-23 Smithkline Beecham Corporation DNA encoding tumor necrosis related receptor, TR4
CA2257247C (fr) 1997-04-15 2012-09-11 Snow Brand Milk Products Co., Ltd. Nouvelle proteine se liant au facteur inhibitoire de l'osteoclastogenese et procede de fabrication
US6316408B1 (en) 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
SI0975754T2 (sl) 1997-04-16 2016-04-29 Amgen Inc., Vezivni proteini in receptorji osteoprotegerina
US6346388B1 (en) 1997-08-13 2002-02-12 Smithkline Beecham Corporation Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2
CN1183159C (zh) 1997-09-24 2005-01-05 三共株式会社 破骨细胞形成抑制因子单克隆抗体、其用途和试剂盒
US6297022B1 (en) 1997-10-08 2001-10-02 Smithkline Beecham Corporation Method of identifying agonists and antagonists for tumor necrosis related receptor TR1
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
NZ530765A (en) 2001-06-26 2006-11-30 Amgen Fremont Inc Antibodies that bind OPGL and compositions and methods for the treatment of bone diseases
EP2314316A1 (fr) 2002-04-05 2011-04-27 Amgen, Inc Anticorps humain anti-OPGL neutralizant comme inhibiteurs selectifs de la voie de signalisaition par l'OPGL
JP4050593B2 (ja) 2002-11-01 2008-02-20 日本特殊陶業株式会社 ガスセンサ素子及びこれを用いたガスセンサ

Also Published As

Publication number Publication date
JP2002320479A (ja) 2002-11-05
ZA952587B (en) 1996-11-27
WO1996028546A1 (fr) 1996-09-19

Similar Documents

Publication Publication Date Title
AU708972B2 (en) Tumor necrosis factor-gamma
EP2017337A1 (fr) Récepteur du facteur onconécrosant humain
AU708903B2 (en) Human chemokine polypeptides
US7094564B1 (en) Human tumor necrosis factor receptor
CA2211003A1 (fr) Recepteur du facteur de necrose des tumeurs humain
AU723891B2 (en) Human chemokine beta-11 and human chemokine alpha-1
US6458349B1 (en) Chemokine β-4 polypeptides
JP2001501453A (ja) ヒト腫瘍壊死因子δおよびε
CA2210444C (fr) Facteur-2 de croissance des keratinocytes
AU713267B2 (en) Human chemokine beta-13
US20030166097A1 (en) Human tumor necrosis factor receptor
WO1998012344A1 (fr) Genes de type recepteurs du facteur de necrose tumorale humain
WO1996039520A1 (fr) Chemokine beta-12 humaine
US20040126371A9 (en) Immune cell cytokine
WO1996023410A1 (fr) Enzymes 7, 8 et 9 de conjugaison d'ubiquitine
US6130061A (en) Human stem cell antigen 2
AU753730B2 (en) Human chemokine beta-13
US20040038347A1 (en) Apoptosis inducing molecule I
AU750982B2 (en) Human chemokine beta-11 and human chemokine alpha-1
AU753088B2 (en) Human chemokine polypeptides
CA2215383A1 (fr) Recepteur humain du facteur de necrose tumorale
AU753309B2 (en) Pineal gland specific gene-1
US5945321A (en) Ubiquitin conjugating enzymes 7, 8 and 9
AU716415B2 (en) Pineal gland specific gene-1
EP0815220A1 (fr) Transporteur d'amine humaine

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead